跳至主要内容
临床试验/JPRN-UMIN000008844
JPRN-UMIN000008844已完成4 期

Evaluation of clinical guideline and establishment of evidence for the diagnosis and treatment of primary hyperaldosteronism in Japan. - PHAS-J3

ational Hospital Organization0 个研究点目标入组 2,641 人开始时间: 2012年9月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
2,641

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)pregnant patients 2)patients taking aldosterone antagonist within the last one month 3)patients with the following diseases: (1)secondary hypertension (renal hypertension,renovascular hypertension, primary aldosteronism, Cushing's syndrome, pheochromocytoma, etc) (2)patients whom the attending doctors decides not suitable for the entry because of the unstable stage of the following complications: coronary diseases, arrhythmia, severe valvular diseases, cerebrovascular diseases, acute and chronic renal failure (serum Cr higher than 3mg/dl), acute and chronic liver diseases 4) Patients whom the attending doctor decides not suitable for the entry of the study.

研究者

发起方
ational Hospital Organization

相似试验